Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension"


Cite item

Full Text

Abstract

On behalf of the team of co-authors

About the authors

I E Chazova

A.L.Myasnikov Institute of Clinical Cardiology, National Medical Research Center for Cardiology of the Ministry of Health of the Russian Federation

акад. РАН, д.м.н., проф., директор, руководитель отд. гипертонии; ORCID: 0000-0002-9822-4357 Москва, Россия

T V Martynyuk

A.L.Myasnikov Institute of Clinical Cardiology, National Medical Research Center for Cardiology of the Ministry of Health of the Russian Federation

Email: trukhiniv@mail.ru
д.м.н., руководитель отд. легочной гипертензии и заболеваний сердца Москва, Россия

References

  1. Galie N, Manes A, Negro L, et al. A meta - analysis of randomized controlled trials pulmonary arterial hypertension. Eur Heart J. 2009;30:394-403. doi: 10.1093/eurheartj/ehp022
  2. D'Alonzo G.E, Barst R.J, Ayres S.M, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-49.
  3. Kane G.C, Maradit-Kremers H, Slusser J, et al. Integration of Clinical and Hemodynamic Parameters in the Prediction of Long - term Survival in Patients With Pulmonary Arterial Hypertension. Chest. 2011;139(6):1285-93.
  4. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-30. doi: 10.1164/rccm.200510-1668OC
  5. Hoeper M.M, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2). doi: 10.1183/13993003.00740-2017
  6. Волков А.В., Мартынюк Т.В., Юдкина Н.Н., Данилов Н.М., Глухова С.И., Гусева Н.Г., Чазова И.Е., Насонова В.А. Выживаемость пациентов с легочной артериальной гипертензией, ассоциированной с системной склеродермией. Терапевтический архив. 2012;84(5):24-8.
  7. Kylhammar D, Kjellström B, Hjalmarsson C, et al. A comprehensive risk stratification at early follow - up determines prognosis in pulmonary arterial hypertension. Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00889-2017
  8. Boucly A, Weatherald J, Savale L, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017 Aug 3;50(2):pii: 1700889. doi: 10.1183/13993003.00889-2017
  9. Hoeper M.M, Huscher D, Ghofrani H.A, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry. Intern J Cardiology. 2013;168(2):871-80. doi: 10. 1016/j.ijcard.2012.10.026
  10. Galie N, Humbert M, Vachiery J.L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46(4):903-75. doi: 10.1183/13993003.01032-2015
  11. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Circulation. 2009;119:2250-94. doi: 10.1161/CIRCULATIONAHA.109.192230
  12. Федеральные рекомендации по диагностике и лечению легочной гипертензии. http://cr.rosminzdrav.ru/ [Federal recommendations for the diagnosis and treatment of pulmonary hypertension (In Russ.)].
  13. Sitbon O, Channick R, Chin K.M, et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373:2522-33. doi: 10.1056/NEJMoa1503184

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies